Alex Goldberg

NASDAQ Decliners Watch List: Celgene Corporation (NASDAQ:CELG) and Texas Instruments Inc. (NASDAQ:TXN) Added to Equity Profile Report's NASDAQ Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/16/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Celgene Corporation (NASDAQ:CELG) and Texas Instruments Inc. (NASDAQ:TXN).

Celgene Corporation (NASDAQ:CELG) a company that discovers, develops, and commercializes therapies for cancer and immune-inflammatory related diseases in the United States and Europe closed down in its previous session (-0.37%) on 2,704,738 shares traded after Celgene, Agios Extended Tie-up. Celgene Corporation (NASDAQ:CELG) is currently down (-5.64%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Celgene Corporation (NASDAQ:CELG)

Texas Instruments Inc. (NASDAQ:TXN) a company that engages in the design, manufacture, sale of semiconductors to electronics designers and manufacturers worldwide closed down in its previous session (-1.11%) on 5,595,970 shares traded after Texas Instruments was downgraded to Reduce from Neutral at Nomura. Texas Instruments Inc. (NASDAQ:TXN) is currently down (-4.03%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Texas Instruments Inc. (NASDAQ:TXN)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com